Research Paper Volume 13, Issue 4 pp 5263—5283

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma

KPNA4’s expression and prognostic value in HCC patients. (A) The mRNA expression level of KPNA4 was significantly higher in cancerous tissues than in normal tissues in the Metabolic gEne RApid Visualizer. (B) Representative immunohistochemistry images from the HPA with the KPNA4 antibody: HPA045500, cancerous tissue had higher staining than normal liver tissue. (C) High KPNA4 mRNA expression was significantly associated with poor OS in HCC patients from the Kaplan-Meier plotter. (D) Prognostic value of the KPNA4 level in HCC patients from the HPA.

Figure 6. KPNA4’s expression and prognostic value in HCC patients. (A) The mRNA expression level of KPNA4 was significantly higher in cancerous tissues than in normal tissues in the Metabolic gEne RApid Visualizer. (B) Representative immunohistochemistry images from the HPA with the KPNA4 antibody: HPA045500, cancerous tissue had higher staining than normal liver tissue. (C) High KPNA4 mRNA expression was significantly associated with poor OS in HCC patients from the Kaplan-Meier plotter. (D) Prognostic value of the KPNA4 level in HCC patients from the HPA.